SCHEMBL15568488

SCHEMBL15568488

CC(C)(C)N(C(=O)O)C1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(CCc4ccccc4CC(N)=O)n3)cc2)CC1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14643094 0.90 PTK2 (0.84) PTK2
SCHEMBL14576350 0.88 PTK2 (1.00) PTK2
SCHEMBL12478987 0.87 PTK2 (0.83) PTK2
SCHEMBL14577085 0.86 PTK2 (1.00) PTK2
SCHEMBL12479002 0.85 PTK2 (1.00) PTK2
SCHEMBL12478738 0.85 PTK2 (0.86) PTK2
SCHEMBL12479296 0.85 PTK2 (1.00) PTK2
SCHEMBL14643156 0.84 PTK2 (0.76) PTK2
SCHEMBL14577232 0.84 PTK2 (1.00) PTK2
SCHEMBL14643093 0.82 PTK2 (0.82) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421205-B2 FAK inhibitors Cancer Therapeutics CRC Pty Ltd. (AU) 2016-08-23 — — US disclosed
WO-2014027199-A1 FAK AND FLT3 INHIBITORS CANCER THERAPEUTICS CRC PTY LTD (AU) 2014-02-20 — — WO disclosed
Send feedback